ADC Therapeutics SA (NYSE:ADCT) Q4 2024 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen, and welcome to the ADC Therapeutics Fourth Quarter Fiscal Year 2024 Earnings Conference Call. At this time, all lines are in listen-only mode.